New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Omega Therapeutics, Inc.
OMGA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

8M

Biotechnology

Next Earning date - 27 Mar 2025

8M

Biotechnology

Next Earning date - 27 Mar 2025

0.14USD

0.00 ( 0.00%)
sun-fogPre-market 0.11$arrow-left-down-0.04 (-25.18%)
Market Closed (as of Feb 24, 21:00 EDT)
favorite-chart

Relative Strenght

0
favorite-chart

Volume Buzz

-55%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

97%

Quote Panel

Shape
Updated March 25, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

OMGA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape-23%

2025-Revenue

$1.18

Shape-293%

2025-EPS

$400K

Shape98%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Raymond James

initialise

Previous: Not converted

2024-06-18

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.64
vs -0.44

Q1.23

arrow
arrow

N/A

-0.50
vs -0.42

Q2.23

arrow
arrow

N/A

-0.54
vs -0.54

Q3.23

arrow
arrow

N/A

-0.40
vs -0.54

Q4.23

arrow
arrow

N/A

-0.37
vs -0.64

Q1.24

arrow
arrow

N/A

-0.36
vs -0.50

Q2.24

arrow
arrow

N/A

-0.30
vs -0.54

Q3.24

arrow
arrow

N/A

-0.30
vs -0.40

Q4.24

arrow
arrow

N/A

-0.24
vs -0.37

Q1.25

arrow
arrow

N/A

-0.26
vs -0.36

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+410%

735K  vs 144K

Q1.23

arrow
arrow

+93%

516K  vs 268K

Q2.23

arrow
arrow

+59%

759K  vs 476K

Q3.23

arrow
arrow

+40%

831K  vs 595K

Q4.23

arrow
arrow

+35%

989K  vs 735K

Q1.24

arrow
arrow

+357%

2.4M  vs 516K

Q2.24

arrow
arrow

+181%

2.1M  vs 759K

Q3.24

arrow
arrow

+214%

2.6M  vs 831K

Q4.24

arrow
arrow

-49%

500K  vs 989K

Q1.25

arrow
arrow

-79%

500K  vs 2.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-29%

-0.29
vs -0.19

Q1.23

arrow
arrow

-20%

-0.20
vs -0.29

Q2.23

arrow
arrow

-31%

-0.31
vs -0.20

Q3.23

arrow
arrow

-29%

-0.29
vs -0.31

Q4.23

arrow
arrow

-35%

-0.35
vs -0.29

Q1.24

arrow
arrow

-49%

-0.49
vs -0.35

Q2.24

arrow
arrow

-62%

-0.62
vs -0.49

Q3.24

arrow
arrow

-142%

-1.42
vs -0.62

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

61

61
vs 54

13%

Q2.23

arrow
arrow

62

62
vs 61

2%

Q3.23

arrow
arrow

61

61
vs 62

-2%

Q4.23

arrow
arrow

65

65
vs 61

7%

Q1.24

arrow
arrow

73

73
vs 65

12%

Q2.24

arrow
arrow

69

69
vs 73

-5%

Q3.24

arrow
arrow

55

55
vs 69

-20%

Q4.24

arrow
arrow

53

53
vs 55

-4%

Earnings Growth

Latest News